The medical devices sector is typified by frequent change and innovation, in response to problems and issues faced by the healthcare industry. As a result, the sector has seen the emergence of several start-up medtech companies offering disruptive, cutting-edge solutions. Most of these are private companies, where data such as revenue is frequently not disclosed. National estimates for Santa Cruz Biotechnology sales in the US from 2017 to 2023, as well as year-on-year growth rates, can be viewed in GlobalData’s micro revenue report. Buy the report here.
Smarter leaders trust GlobalData
Santa Cruz Biotechnology Inc (Santa Cruz) is a developer of biomedical research products. The company offers research products, chemicals, lab supplies and animal health products including primary antibodies, secondary antibodies, control antibodies, normal sera, phospho-specific antibodies, flow cytometry and immunofluorescent staining, antibodies for paraffin tissue staining and proteins. Santa Cruz also offers product citations and technical services. The company operates in Germany, China, Hong Kong, Singapore, Thailand, Japan and South Korea. Santa Cruz is headquartered in Dallas, Texas, the US. Key subsidiaries of Santa Cruz Biotechnology include Santa Cruz Biotechnology (Shanghai).
The key metrics of Santa Cruz Biotechnology related to marketed and pipeline products, ongoing clinical trials, active jobs and publications from 2023 are shown below:
As Santa Cruz Biotechnology is a privately held company, it is not required to disclose its financial information and there is no stock listed on an exchange. GlobalData has access to a proprietary data set containing invoice data from over 2,600 healthcare institutions in the US and is therefore able to use estimations of a company’s revenue and growth to value private companies such as Santa Cruz Biotechnology.
For a detailed understanding of the performance of Santa Cruz Biotechnology, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData’s revenue report leverages GlobalData’s SKU tracker, which contains real-world, purchasing data from the US healthcare institutions.
